Skip to main content
. 2023 Feb 15;12(8):9202–9212. doi: 10.1002/cam4.5661

TABLE 4.

Frequency of AEs of any grade or grade 3/4 in patients with ALBI grade 1 versus 2/3.

Patients, n (%) AEs of any grade Grade 3/4 AEs
ALBI grade 1 ALBI grade 2/3 p value ALBI grade 1 ALBI grade 2/3 p value
(n = 104) (n = 106) (n = 104) (n = 106)
Any adverse events 79 (76.0) 88 (83.0) 0.205 40 (38.5) 61 (57.5) 0.006
Hypertension 25 (24.0) 24 (22.6) 0.811 10 (9.6) 13 (12.3) 0.539
Skin rash 8 (7.7) 6 (5.7) 0.555 4 (3.8) 2 (1.9) 0.443
Hand‐foot skin reaction 18 (17.3) 31 (29.2) 0.041 8 (7.7) 11 (10.4) 0.498
Diarrhea 30 (28.8) 29 (27.4) 0.810 12 (11.5) 17 (16.0) 0.345
Fatigue 14 (13.5) 25 (23.6) 0.059 6 (5.8) 18 (17.0) 0.016
Increased blood bilirubin 38 (36.5) 51 (48.1) 0.090 15 (14.4) 34 (32.1) 0.002
Elevated AST/ALT 34 (32.7) 49 (46.2) 0.045 20 (19.2) 39 (36.8) 0.005
Thrombocytopenia 17 (16.3) 12 (11.3) 0.318 6 (5.8) 8 (7.5) 0.606
Decreased appetite 19 (18.3) 32 (30.2) 0.044 10 (9.6) 19 (17.9) 0.109
Hypothyroidism 6 (5.8) 2 (1.9) 0.168 4 (3.8) 1 (0.9) 0.210
Pneumonitis 1 (1.0) 4 (3.8) 0.369 1 (1.0) 4 (3.8) 0.369
Hemorrhage 4 (3.8) 2 (1.9) 0.443 4 (3.8) 2 (1.9) 0.443

Abbreviations: AE, adverse event; ALBI, albumin‐bilirubin; ALT, alanine aminotransferase; AST, aspartate aminotransferase.